Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer

R: A Language and Environment for Statistical Computing

R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,706 · see citing works

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239 · see citing works

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works

Untangling the ErbB signalling network

Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · see citing works

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,848 · see citing works

MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer

Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773 · see citing works

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964 · see citing works

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

Robinson, D. R., Wu, Y.-M., Vats, P., Su, F., Lonigro, R. J., Cao, X., Kalyana-Sundaram, S., Wang, R., Ning, Y., Hodges, L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2823 · Cited by 1,145 · see citing works

Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells

Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141 · see citing works

PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification

Spandidos, A., Wang, X., Wang, H., & Seed, B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1005 · Cited by 900 · see citing works

Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α

Campbell, R., Bhat-Nakshatri, P., Patel, N., Constantinidou, D., Ali, S., & Nakshatri, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010840200 · Cited by 880 · see citing works

Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer

Ivshina, A. V., George, J., Sen'ko, O. V., Mow, B. M. F., Putti, T. C., Smeds, J., Lindahl, T., Yudi Pawitan, Y., Hall, P. N., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 751 · see citing works

S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth

Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731 · see citing works

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711 · see citing works

Breast Cancer

Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270505 · Cited by 698 · see citing works

The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation

Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494 · see citing works

MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression

Liu, L.-Z., Li, C.-Y., Chen, Q., Yi, J., Carpenter, R. L., Jiang, Y., Kung, H., Lai, L., & Jiang, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019139 · Cited by 492 · see citing works

D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

Merenbakh-Lamin, K., Ben-Baruch, N. E., Yeheskel, A., Dvir, A., Soussan‐Gutman, L., Jeselsohn, R. M., Yelensky, R., Brown, M. A., Miller, V. A., Sarid, D. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1197 · Cited by 397 · see citing works

Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

Wickramasinghe, N. S. M. D., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., & Klinge, C. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp117 · Cited by 391 · see citing works

Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

Sun, M., Paciga, J. E., Feldman, R. I., Yuan, Z., Coppola, D., Lu, Y., Shelley, S. A., Nicosia, S. V., & Cheng, J. Q. (2001) · PubMed · Cited by 361 · see citing works

MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand

Sayed, D. H., He, M., Hong, C., Gao, S., Rane, S., Yang, Z., & Abdellatif, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109207 · Cited by 313 · see citing works

The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation

Lankat–Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 307 · see citing works

Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation

Martin, L., Farmer, I., Johnston, S. R. D., Ali, S., Marshall, C., & Dowsett, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305226200 · Cited by 295 · see citing works

Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

Mauri, D. N., Pavlidis, N. A., Polyzos, N. P., & Ioannidis, J. P. A. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj357 · Cited by 286 · see citing works

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

Chen, Y., Knösel, T., Kristiansen, G., Pietas, A., Garber, M. E., Matsuhashi, S., Ozaki, I., & Petersen, I. (2003) · The Journal of Pathology · doi:10.1002/path.1378 · Cited by 265 · see citing works

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254 · see citing works

Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma

Zhang, H., Ozaki, I., Mizuta, T., Hamajima, H., Yasutake, T., Eguchi, Y., Ideguchi, H., Yamamoto, K., & Matsuhashi, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209634 · Cited by 247 · see citing works

Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth

Maillot, G., Lacroix‐Triki, M., Pierredon, S., Gratadou, L., Schmidt, S., Beneš, V., Roche, H. H., Dalenc, F., Auboeuf, D., Millevoi, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2206 · Cited by 241 · see citing works

Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death

Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223 · see citing works

Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis

Jansen, A. P., Camalier, C. E., & Colburn, N. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2119 · Cited by 212 · see citing works

Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.

Zhou, D. J., Pompon, D., & Chen, S. A. (1990) · PubMed · Cited by 210 · see citing works

Activation of PI3K/Akt signaling and hormone resistance in breast cancer

Tokunaga, E., Kimura, Y., Mashino, K., Oki, E., Kataoka, A., Ohno, S., Morita, M., Kakeji, Y., Baba, H., & Maehara, Y. (2006) · Breast Cancer · doi:10.2325/jbcs.13.137 · Cited by 201 · see citing works

A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A

Yang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199 · see citing works

Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

Mudduluru, G., Medved, F., Grobholz, R., Jost, C., Gruber, A., Leupold, J. H., Post, S., Jansen, A., Colburn, N. H., & Allgayer, H. (2007) · Cancer · doi:10.1002/cncr.22983 · Cited by 196 · see citing works

Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion

Huang, T.-H., Wu, F., Loeb, G. B., Hsu, R., Heidersbach, A., Brincat, A., Horiuchi, D., Lebbink, R. J., Mo, Y.-Y., Goga, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006676 · Cited by 191 · see citing works

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

Hayes, E., & Lewis-Wambi, J. S. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0542-y · Cited by 170 · see citing works

Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis

Afonja, O., Juste, D., Das, S., Matsuhashi, S., & Samuels, H. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207983 · Cited by 154 · see citing works

A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer

Fox, E. M., Miller, T. W., Balko, J. M., Kuba, M. G., Sanchez, V. M., Smith, R. A., Liu, S., Gonzalez-Angulo, A. M., Mills, G. B., Ye, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1295 · Cited by 153 · see citing works

Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion

Schmid, T., Jansen, A. P., Baker, A. R., Hegamyer, G., Hagan, J. P., & Colburn, N. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1719 · Cited by 151 · see citing works

Activation of Mitogen-Activated Protein Kinase in Xenografts and Cells during Prolonged Treatment with Aromatase Inhibitor Letrozole

Jelovac, D., Sabnis, G. J., Long, B. J., Macedo, L. F., Goloubeva, O. G., & Brodie, A. M. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4502 · Cited by 139 · see citing works

Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity

Santen, R. J., Song, R., Zhang, Z., Kumar, R., Jeng, M. H., Masamura, A., Lawrence, J., Berstein, L. M., & Yue, W. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01018 · Cited by 125 · see citing works

Genome-Wide Analysis of Aromatase Inhibitor-Resistant, Tamoxifen-Resistant, and Long-Term Estrogen-Deprived Cells Reveals a Role for Estrogen Receptor

Masri, S., Phung, S., Wang, X., Wu, X., Yuan, Y., Wagman, L. D., & Chen, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0303 · Cited by 104 · see citing works

The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells

Masri, S., Liu, Z., Phung, S., Wang, E., Yuan, Y., & Chen, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0716-3 · Cited by 103 · see citing works

Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation

Martin, L., Farmer, I., Johnston, S. R. D., Ali, S., & Dowsett, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01023 · Cited by 82 · see citing works

Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast

Lee, J. A., Lee, H. Y., Lee, E. S., Kim, I., & Bae, J. W. (2011) · Journal of Breast Cancer · doi:10.4048/jbc.2011.14.4.269 · Cited by 82 · see citing works

Alterations in the expression of PDCD4 in ductal carcinoma of the breast

Wen, Y., Shi, X., Chiriboga, L. A., Matsahashi, S., Yee, H. T., & Afonja, O. (2007) · Oncology Reports · doi:10.3892/or.18.6.1387 · Cited by 81 · see citing works

Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer

Meric‐Bernstam, F., Chen, H., Akçakanat, A., Do, K.-A., Lluch, A. M., Hennessy, B. T., Hortobágyi, G. N., Mills, G. B., & Gonzalez-Angulo, A. M. (2012) · Breast Cancer Research · doi:10.1186/bcr3343 · Cited by 79 · see citing works

Membrane receptors for steroid hormones: Signal transduction and physiological significance

Nemere, I., Pietras, R. J., & Blackmore, P. F. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10409 · Cited by 76 · see citing works

Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation

Maruani, D. M., Spiegel, T. N., Harris, E., Shachter, A., Unger, H. A., Herrero‐González, S., & Holz, M. K. (2012) · Oncogene · doi:10.1038/onc.2011.657 · Cited by 76 · see citing works

Insulin-like Growth Factor Receptor Levels Are Regulated by Cell Density and by Long Term Estrogen Deprivation in MCF7 Human Breast Cancer Cells

Stephen, R. L., Shaw, L. E., Larsen, C., Corcoran, D. L., & Darbre, P. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105892200 · Cited by 67 · see citing works

Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: Effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism

Chen, Z., Wang, O., Nie, M., Elison, K., Zhou, D., Li, M., Jiang, Y., Xia, W., Meng, X., Chen, S., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.016 · Cited by 54 · see citing works

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer

Gilani, R. A., Kazi, A. A., Shah, P., Schech, A. J., Chumsri, S., Sabnis, G. J., Jaiswal, A. K., & Brodie, A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2148-8 · Cited by 44 · see citing works

Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors

Flågeng, M. H., Moi, L. L. H., Dixon, J. M., Geisler, J., Lien, E. A., Miller, W. R., Lønning, P. E., & Mellgren, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605324 · Cited by 42 · see citing works

Endocrine Resistance in Breast Cancer: Molecular Pathways and Rational Development of Targeted Therapies

Roop, R. P., & Ma, C. X. (2012) · Future Oncology · doi:10.2217/fon.12.8 · Cited by 40 · see citing works

AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies

Wong, C., Wang, X., Smith, D. D., Reddy, K. B., & Chen, S. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2105-6 · Cited by 20 · see citing works

Emerging role of microRNA-21 in cancer

Feng, Y., & Tsao, C. (2016) · Biomedical Reports · doi:10.3892/br.2016.747 · Cited by 456 · see citing works

Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions

Matsuhashi, S., Manirujjaman, M., Hamajima, H., & Ozaki, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092304 · Cited by 143 · see citing works

Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases

Zhang, T., Yang, Z., Kusumanchi, P., Han, S., & Liangpunsakul, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00007 · Cited by 139 · see citing works

Bone marrow‐derived mesenchymal stem cell‐derived exosomal microRNA‐208a promotes osteosarcoma cell proliferation, migration, and invasion

Qin, F., Tang, H., Zhang, Y., Zhang, Z., Huang, P., & Zhu, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29351 · Cited by 121 · see citing works

Acquired resistance to aromatase inhibitors: where we stand!

Augusto, T. V., Correia‐da‐Silva, G., Rodrigues, C., Teixeira, N. A. A., & Amaral, C. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0425 · Cited by 109 · see citing works

miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer

Hu, X., Wang, Y., Liang, H., Fan, Q., Zhu, R., Cui, J., Zhang, W., Zen, K., Zhang, C., Hou, D., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.447 · Cited by 84 · see citing works

MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells

Feng, M.-G., Liu, C.-F., Chen, L., Feng, W.-B., Liu, M., Hai, H., & Lu, J.-M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.043 · Cited by 80 · see citing works

SERPINA1is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients

Chan, H. J., Li, H., Liu, Z., Yuan, Y., Mortimer, J. E., & Chen, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4441 · Cited by 78 · see citing works

microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy

Howard, E. W., & Yang, X. (2018) · Biological Procedures Online · doi:10.1186/s12575-018-0082-9 · Cited by 70 · see citing works

Eukaryotic translation initiation factors and cancer

Ali, M. U., Rahman, M. S. U., Jia, Z., & Jiang, C. (2017) · Tumor Biology · doi:10.1177/1010428317709805 · Cited by 69 · see citing works

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Dytfeld, D., Łuczak, M., Wróbel, T., Usnarska‐Zubkiewicz, L., Brzeźniakiewicz‐Janus, K., Jamroziak, K., Giannopoulos, K., Przybyłowicz-Chalecka, A., Ratajczak, B., Czerwińska-Rybak, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11059 · Cited by 66 · see citing works

MicroRNAs regulate the epithelial–mesenchymal transition and influence breast cancer invasion and metastasis

Zhao, M., Ang, L., Huang, J., & Wang, J. (2017) · Tumor Biology · doi:10.1177/1010428317691682 · Cited by 58 · see citing works

Unravelling exemestane: From biology to clinical prospects

Sobral, A. F., Amaral, C., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.019 · Cited by 48 · see citing works

Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4

Nedaeinia, R., Sharifi, M., Avan, A., Kazemi, M., Nabinejad, A., Ferns, G. A., Ghayour-Mobarhan, M., & Salehi, R. (2017) · Tumor Biology · doi:10.1177/1010428317692261 · Cited by 47 · see citing works

Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma

Huang, D., Wei, Y., Zhu, J., & Wang, F. (2019) · Gene · doi:10.1016/j.gene.2019.143994 · Cited by 44 · see citing works

PDCD4 suppresses proliferation, migration, and invasion of endometrial cells by inhibiting autophagy and NF-κB/MMP2/MMP9 signal pathway†

Li, Y., Wang, X., Wang, X., Wan, L., Liu, Y., Shi, Y., Zhang, L., Fang, Z., & Wei, Z. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy052 · Cited by 42 · see citing works

Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway

Li, J., Huang, L., He, Z., Chen, M., Ding, Y., Yao, Y., Duan, Y., Li, Z., Qi, C., Zheng, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643525 · Cited by 39 · see citing works

Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer

Dimitrakopoulos, F.-I. D., Kottorou, A. E., & Tzezou, A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.030 · Cited by 38 · see citing works

A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA

Kwak, G., Kim, H., Park, J., Kim, E. H., Jang, H., Han, G., Wang, S. Y., Yang, Y., Kwon, I. C., & Kim, S. H. (2021) · ACS Nano · doi:10.1021/acsnano.1c00799 · Cited by 38 · see citing works

Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis

Gao, G., Liang, X., & Ma, W. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1666861 · Cited by 37 · see citing works

Dissecting the Roles of PDCD4 in Breast Cancer

Cai, Q., Yang, H., Li, Y., & Zhu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855807 · Cited by 37 · see citing works

The Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer

Zhao, M., Zhu, N., Hao, F., Song, Y., Wang, Z., Ni, Y., & Ding, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00919 · Cited by 36 · see citing works

Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells

Zhou, Q., Zeng, H., Ye, P., Shi, Y. H., Guo, J., & Long, X. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000623 · Cited by 34 · see citing works

The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population

Wilson, T. R., Yu, J., Lu, X., Spoerke, J. M., Xiao, Y., O'Brien, C. L., Savage, H. M., Huw, L., Zou, W., Koeppen, H., et al. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2016.22 · Cited by 29 · see citing works

Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods

Ye, P., Fang, C., Zeng, H., Shi, Y. H., Pan, Z., An, N., He, K., Zhang, L., & Long, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7768 · Cited by 27 · see citing works

PDCD4 Simultaneously Promotes Microglia Activation via PDCD4–MAPK–NF-κB Positive Loop and Facilitates Neuron Apoptosis During Neuroinflammation

Chen, Q., Lu, H., Duan, C., Zhu, X., Zhang, Y., Li, M., & Zhang, D. (2021) · Inflammation · doi:10.1007/s10753-021-01541-9 · Cited by 25 · see citing works

Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer

Treeck, O., Haerteis, S., & Ortmann, O. (2023) · Cancers · doi:10.3390/cancers15061632 · Cited by 24 · see citing works

Analysis of the microRNA Expression Profile of Bovine Monocyte-derived Macrophages Infected with Mycobacterium avium subsp. Paratuberculosis Reveals that miR-150 Suppresses Cell Apoptosis by Targeting PDCD4

Wang, Z., Kong, L. C., Jia, B., Chen, J. R., Dong, Y., Jiang, X., & Hong, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112708 · Cited by 21 · see citing works

PLEKHA5 regulates tumor growth in metastatic melanoma

Zhang, H., Zhu, H., Deng, G., Zito, C. R., Oria, V. O., Rane, C. K., Zhang, S., Weiss, S. A., Tran, T. T. T., Adeniran, A., et al. (2019) · Cancer · doi:10.1002/cncr.32611 · Cited by 21 · see citing works

circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4

Cai, Y., Zhao, X., Chen, D., Zhang, F., Chen, Q., Shao, C.-C., Ouyang, Y.-X., Feng, J. L., Cui, L., Chen, M., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.013 · Cited by 19 · see citing works

Regulation of microRNA ‐21 expression by natural products in cancer

Shakeri, A., Ghanbari, M., Tasbandi, A., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7069 · Cited by 18 · see citing works

Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4

Pin, G., Yu, Y., Tian, Z., Lin, Y., Qiu, Y., Yao, W., & Zhang, L. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4498 · Cited by 18 · see citing works

Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer

Shekari, N., Asghari, F., Haghnavaz, N., Shanehbandi, D., Khaze, V., Baradaran, B., & Kazemi, T. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666181213110258 · Cited by 18 · see citing works

Stat‐3 signaling promotes cell proliferation and metastasis of gastric cancer through PDCD4 downregulation

Yang, Y., Liu, P., Li, D., Yang, Q., Li, B., & Jiang, X. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12159 · Cited by 18 · see citing works

Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer.

Jurkovičová, D., Magyerkova, M., Sestakova, Z., Copáková, L., Bella, V., Konečný, M., Krivjanska, M., Kulcsár, Ľ., & Chovanec, M. (2016) · Neoplasma (Bratislava) · doi:10.4149/neo_2016_613 · Cited by 17 · see citing works

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence

Wang, Y., Jing, F., & Wang, H. (2022) · Advances in Therapy · doi:10.1007/s12325-021-01924-2 · Cited by 16 · see citing works

Discovery of a novel role of tumor suppressor PDCD4 in stimulation of translation termination

Shuvalova, E., Egorova, T., Ivanov, A., Shuvalov, A. V., Biziaev, N., Mukba, S., Pustogarov, N., Terenin, I. M., & Alkalaeva, E. Z. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101269 · Cited by 15 · see citing works

Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis

Madera, S., Chervo, M. F., Chiauzzi, V. A., Pereyra, M. G., Venturutti, L., Izzo, F., Deamicis, A. R., Guzmán, P., Dupont, A., Roa, J. C., et al. (2020) · Hormones and Cancer · doi:10.1007/s12672-020-00392-4 · Cited by 12 · see citing works

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

Tran, T. T. T., Rane, C. K., Zito, C. R., Weiss, S. A., Jessel, S., Lucca, L. E., Lu, B. Y., Oria, V. O., Adeniran, A., Chiang, V., et al. (2021) · Cancers · doi:10.3390/cancers13051049 · Cited by 12 · see citing works

Non-coding RNAs regulating programmed cell death and its implications in cancer chemotherapy resistance

Chen, M., Zhao, P., Chou, J., Zhou, L., Feng, Z., Hao, X., Song, H., & Yang, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144888 · Cited by 11 · see citing works

Down-regulation of microRNA-23b aggravates LPS-induced inflammatory injury in chondrogenic ATDC5 cells by targeting PDCD4.

Yang, Z., Tang, Y.-X., Zhao, Q., Lu, H., & Xu, G. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2018.25856.6364 · Cited by 11 · see citing works

miR-21a inhibits decidual cell apoptosis by targeting Pdcd4

Li, R., Wen, Y., Geng, Y., Zhou, Y., Zhang, Y., Ding, Y., Chen, X., Gao, R., He, J., Wang, Y., et al. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.09.013 · Cited by 10 · see citing works

Circular RNA hsa_circ_0026344 suppresses gastric cancer cell proliferation, migration and invasion via the miR-590-5p/PDCD4 axis

Lv, L., Du, J., Wang, D., & Yan, Z. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac032 · Cited by 10 · see citing works

Prognostic significance of miR‐21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection

Zhang, J., Ma, L., Shi, D., Zhang, Z., Yao, C., Zhao, X., Xu, Q., Wen, P., & He, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26672 · Cited by 9 · see citing works

Gene Selection for the Discrimination of Colorectal Cancer

Wang, W., Xie, G., Ren, Z., Xie, T., & Li, J. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666191119105209 · Cited by 9 · see citing works

Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis

Mishra, P., Kiebish, M. A., Cullen, J., Srinivasan, A., Patterson, A., Sarangarajan, R., Narain, N. R., & Dobi, A. L. (2019) · Genes & Cancer · doi:10.18632/genesandcancer.196 · Cited by 9 · see citing works

Exploring miR-21 Knock-Out Using CRISPR/Cas as a Treatment for Lung Cancer

Lara, P., Aguilar-González, A., Martı́n, F., Mesas, C., Moreno, J., & Rama, A. R. (2025) · Genes · doi:10.3390/genes16020133 · Cited by 8 · see citing works

Atg7 senses ATP levels and regulates AKT1-PDCD4 phosphorylation-ubiquitination axis to promote survival during metabolic stress

Deng, C., Li, C., Dong, X. D., Yu, Y., Guo, W., Guan, Y., Sun, X., & Cao, L. (2023) · Communications Biology · doi:10.1038/s42003-023-05656-7 · Cited by 8 · see citing works

Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression

Yang, W. H., George, A. P., Wang, C., Yang, R. H., Duncan, A. M., Patel, D., Neil, Z. D., & Yang, W. (2023) · Current Oncology · doi:10.3390/curroncol30020124 · Cited by 6 · see citing works

Association of human papillomavirus with breast cancer: a new perspective on an old debate

Purrahman, D., Avarvand, A. Y., Paradowska‐Gorycka, A., Saki, N., Karimpourian, H., Jodat, H., & Mahmoudian‐Sani, M. (2022) · Future Oncology · doi:10.2217/fon-2021-1158 · Cited by 6 · see citing works

Experimental study on the inhibition effect of miR-106a inhibitor on tumor growth of ovarian cancer xenografts mice

Cai, Z., Chen, L., Liang, Y., Shi, J., Ma, Y.-J., Wang, W., & Yang, H. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.05.008 · Cited by 6 · see citing works

Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma

Chen, X., Wu, W., Chen, X., & Gong, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4476-x · Cited by 4 · see citing works

Thioridazine upregulates programmed cell death 4 to induce apoptosis in nasopharyngeal carcinoma through the PI3K/Akt signalling pathway

Liu, J., Ying, M., Zhang, J., Tu, W., Zeng, C., Wu, B., Wang, Q., Shen, H., Zhu, Z., & Cai, H. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000574 · Cited by 4 · see citing works

Discovery of Protein Biomarkers Associated to Tamoxifen Resistance

Marchi, T. D. (2016)

Role of PDCD4 in inflammation and tumors: a double-edged sword

Jia, Y., Chen, X., & Zhang, L. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00164

Molecular Basis of Simalikalactone D Sensitivity in Triple-Negative Breast Cancer Cells

Sánchez-Álvarez, A. O., Nieves-Reyes, J., Borges-Vélez, G., Pérez‐Santiago, J., Rivera-García, M., Alicea-Ayala, S., Ospina, C. A., Valiyeva, F., & Vivas‐Mejía, P. E. (2025) · Biomolecules · doi:10.3390/biom15111561

Subcellular Localization of PDCD4 in Melanoma and Its Prognostic Implications in Tumor and Immune Compartments

Silva, J. S., Costa, M., & Pereira, F. (2022) · Asian journal of Current Research in Clinical Cancer · doi:10.51847/wg1ki8fsew

Targeting MicroRNA networks in solid cancers: mechanisms, biomarkers, delivery systems, and AI-enabled therapies

Viknesh, K., Manoharan, J., Cho, W. C., Alothaim, A. S., Vijayakumar, R., Vijayalakshmi, P., Yogeswari, C., Ramanathan, S., Likson, A., Desai, D., et al. (2026) · Chemical Papers · doi:10.1007/s11696-026-05399-9

Dissecting the Roles of PDCD4 in Breast Cancer

Cai, Q., Yang, H., Li, Y., & Zhu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855807 · Cited by 37 · see citing works

Alterations in the expression of PDCD4 in ductal carcinoma of the breast

Wen, Y., Shi, X., Chiriboga, L. A., Matsahashi, S., Yee, H. T., & Afonja, O. (2007) · Oncology Reports · doi:10.3892/or.18.6.1387 · Cited by 81 · see citing works

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer

Gilani, R. A., Kazi, A. A., Shah, P., Schech, A. J., Chumsri, S., Sabnis, G. J., Jaiswal, A. K., & Brodie, A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2148-8 · Cited by 44 · see citing works

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer

Al-Qasem, A. J., Alves, C. L., Ehmsen, S., Tuttolomondo, M., Terp, M. G., Johansen, L. E., Vever, H., Hoeg, L. V. A., Eliáš, D., Bak, M., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00311-6 · Cited by 92 · see citing works

Abstract 4754: Androgen receptor acquires an oncogenic role in the AI resistance mechanism in breast cancer

Fujii, R., Hanamura, T., Niwa, T., Yamaguchi, Y., Ishida, T., Sasano, H., Ohuchi, N., & Hayashi, S. (2014) · Cancer Research · doi:10.1158/1538-7445.am2014-4754